Multiple Assemblies exist for SMTL entry 8qw6
Crystal Structure of compound 3 in complex with KRAS G12V C118S GDP and pVHL:ElonginC:ElonginB; X-RAY DIFFRACTION 2.20 Å

SMTL ID 8qw6.1 Ligands GUANOSINE-5'-DIPHOSPHATE; (2S,4R)-1-[(2S)-2-[6-[(3S)-4-[4-[5-[(4S)-2-azanyl-3-cyano-4-methyl-6,7-dihydro-5H-1-benzothiophen-4-yl]-1,2,4-oxadiazol-3-yl]pyrimidin-2-yl]-3-methyl-1,4-diazepan-1-yl]hexanoylamino]-3,3-dimethyl-butanoyl]-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide; MAGNESIUM ION Polypeptides Elongin-B; Elongin-C; von Hippel-Lindau disease tumor suppressor; GTPase KRas Oligo-state hetero-1-1-1-1-mer

SMTL ID 8qw6.2 Ligands GUANOSINE-5'-DIPHOSPHATE; (2S,4R)-1-[(2S)-2-[6-[(3S)-4-[4-[5-[(4S)-2-azanyl-3-cyano-4-methyl-6,7-dihydro-5H-1-benzothiophen-4-yl]-1,2,4-oxadiazol-3-yl]pyrimidin-2-yl]-3-methyl-1,4-diazepan-1-yl]hexanoylamino]-3,3-dimethyl-butanoyl]-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide; MAGNESIUM ION Polypeptides Elongin-B; Elongin-C; von Hippel-Lindau disease tumor suppressor; GTPase KRas Oligo-state hetero-1-1-1-1-mer